(Q45964186)

English

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

phase III clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Stephan N. Wagner

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

author name string

Jeffrey S Weber

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Hassan Zarour

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Bruce Redman

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Uwe Trefzer

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Steven O'Day

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Alfons J M van den Eertwegh

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Ernest Marshall

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

115

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

17

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

3944-3954

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

21 January 2018

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

21 January 2018

Pathogen recognition with Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Innate immune recognition of viral infection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Mammalian Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of Toll-like receptor molecules on human platelets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Alerting dendritic cells to pathogens: the importance of Toll-like receptor signaling of stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling in B cells via Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG oligodeoxynucleotide enhances tumor response to radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

CpG motifs are efficient adjuvants for DNA cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

New approaches to the systemic treatment of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24473

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24473

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19536884

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45964186&oldid=1981744716"